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Abstract Mucinous cystic neoplasm of the liver (MCN-
L) is a very rare tumor whose detailed behavior is still
unknown. We describe two cases of MCN-L that exhibited
extremely interesting growth patterns, and discuss the
characteristics of MCN-Ls. Both cases exhibited MCN-L
that originated from the left hepatic lobe (Segment 4) and
then prolapsed into the left hepatic duct and common bile
duct, resulting in obstructive jaundice due to expansive
growth. Endoscopic retrograde cholangiopancreatographies
showed the characteristic oval-shaped filling defects in the
bile ducts. Endoscopic ultrasound and intraductal ultra-
sound were useful for differentiating the tumors from
stones, since multiple septal formations were observed
inside the tumors. A literature search revealed that, over the
past 10 years, 15 cases of MCN-L (biliary cystadenomas
with ovarian-like stroma) that showed expansive growth in
the bile duct had been reported. Prolapse into the bile duct
and expansive growth appear to be characteristic behavior
of MCN-L. In the future, additional data on more cases
needs to be collected to further elucidate MCN-L
pathophysiology.
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Mucinous cystic neoplasm of the liver (MCN-L) is an ex-
tremely rare cyst-forming epithelial tumor. This unique neo-
plasm is commonly observed in middle-aged women and is
usually characterized by having no communication with the
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bile duct and rarely becoming malignant. Pathologically, the
cyst wall is composed of mucin-producing cuboidal or
columnar epithelium and is accompanied by ovarian-like
stroma (OLS). However, detailed information on the behavior
of MCN-L is lacking due to its rarity.
Along with a review of the literature, we describe
two cases of MCN-L that exhibited extremely inter-




A 57-year-old woman was admitted to the emergency room
complaining of sudden abdominal pain and fever. Her vital
signs were blood pressure 120/76 mmHg, heart rate 102
beats/min, and body temperature 38.2 C. Tenderness was
noted from the epigastrium to the hypochondriac region,
but neither muscular defense nor rebound tenderness was
observed. Laboratory tests revealed elevated levels of
hepato-biliary enzymes (T-bil: 2.7 mg/dL; GOT: 299 U/L;
GPT: 535 U/L; ALP: 2459 U/L; c-GTP: 2054 U/L). Cancer
antigen (CA) 19-9 levels were mildly increased (99.0
U/mL, normal = 0-37 U/mL) and carcinoembryonic
antigen (CEA) levels were normal (^0.5 ng/mL, nor-
mal = 0-0.5 ng/mL). Both the hepatitis B surface antigen
(HBsAg) and the hepatitis C virus antibody (HCVAb) tests
were negative, and the patient had no history of excessive
alcohol consumption.
Contrast abdominal computed tomography (CT) re-
vealed a 83 9 80 mm multi-locular cystic lesion with an
internal septal formation in the left hepatic lobe (Segment
4: S4) (Fig. 1a). No nodular components, ductal invasion,
or distant metastases were found. Magnetic resonance
imaging (MRI) showed low signal intensities on T1-
weighted images and high signal intensities on T2-
weighted images inside the cystic lesion (Fig. 1b). The
septal formation was connected to the left hepatic duct and
common bile duct, and spread of the tumor to the bile duct
was suspected (Fig. 1c). Endoscopic retrograde cholan-
giopancreatography (ERCP) was performed, and no ex-
cretion of mucin from the papilla of Vater was observed.
Cholangiography revealed an oval-shaped filling defect in
the common bile duct (Fig. 1d). There were no findings
Fig. 1 a Contrast abdominal CT revealed a multi-locular cystic
lesion in the left hepatic lobe (S4), with multiple septal formations
(arrow). Intrahepatic bile ducts were dilated. b, c MRI showed high
signal intensities on T2-weighted images of the components inside the
cyst (arrow). The septal formation was connected to the left hepatic
duct and common bile duct (arrow), and thus the spread of the tumor
into the bile duct was suspected. d ERCP revealed an oval-shaped
filling defect that appeared to fill the common bile duct (arrow).
e Cholangioscopy enabled a direct observation of the tumor filling the
common bile duct. f EUS revealed that the tumor occupied the lumen
of the common bile duct, and many septal formations were observed
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indicating malignancy in the bile cytology. Cholan-
gioscopy enabled a direct observation of the smooth tumor
wall inside the common bile duct (Fig. 1e). Endoscopic
ultrasound (EUS) revealed that the tumor occupied the
lumen of the common bile duct, and many septal forma-
tions were observed (Fig. 1f). On the basis of the above
findings, the patient was diagnosed with benign MCN-L
that had prolapsed into the bile duct. The patient underwent
a laparoscopy-assisted left lobectomy, a cholecystectomy,
and a right hepaticojejunostomy. The patient progressed
well following the surgical procedures and was discharged
from the hospital 14 days postoperatively.
Macroscopic findings indicated a multi-locular cystic
tumor in S4 of the liver. It had prolapsed into the left
hepatic duct and common bile duct (Fig. 2a, b). Micro-
scopic findings revealed that the cystic lesion was lined
with mucinous cuboidal epithelium, and OLS was observed
extensively in the cyst wall stroma (Fig. 3). The OLS was
positive for both progesterone and estrogen receptors. A
definitive diagnosis of MCN-L with low-grade dysplasia
was therefore made.
Case 2
A 26-year-old woman visited our hospital after being told
by a family member that her eyes appeared yellow. Her
vital signs were blood pressure 110/72 mmHg, heart rate
68 beats/min, and body temperature 36.2 C. She presented
no tenderness in the abdominal region. Laboratory tests
revealed elevated levels of hepato-biliary enzymes (T-bil:
4.1 mg/mL; GOT: 271 U/L; GPT: 394 U/L; ALP: 1568
U/L; c-GTP: 489 U/L). Tumor marker levels were normal
(CA 19-9: 5.5 U/mL; CEA ^0.5 ng/mL). Both HBsAg
and HCVAb were negative and the patient had no history
of excessive alcohol consumption.
Contrast abdominal CT revealed a 61 9 39 mm multi-
locular cystic lesion with internal septal formation in the
left hepatic lobe (S4), but no nodular components were
contained (Fig. 4a). No ductal invasion or distant metas-
tases were found. MRI showed low signal intensities on
T1-weighted images and high signal intensities on T2-
weighted images inside the cyst (Fig. 4b). The septal for-
mation was connected to the left hepatic duct and common
bile duct, and thus the spread of the tumor to the bile duct
was suspected (Fig. 4c). ERCP demonstrated no excretion
of mucin from the papilla of Vater. Cholangiography re-
vealed a filling defect in the upper bile duct, and the lower
tip of the defect area was oval-shaped. Furthermore,
stenosis of the left hepatic duct was observed (Fig. 4d).
There were no findings indicating malignancy in the bile
cytology. IDUS revealed the spread of the tumor to the left
Fig. 2 a An incision was made in the common bile duct, which was filled with the tumor (arrow). b A multi-locular cystic tumor was noted in
the S4 liver segment, and had prolapsed into the left hepatic duct and common bile duct
Fig. 3 Microscopic findings revealed that the cystic lesion was lined
with mucinous cuboidal epithelium, and OLS was observed exten-
sively in the cyst wall stroma. MCN-L with low-grade dysplasia was
diagnosed
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hepatic duct and common bile duct, with a number of
septal formations inside the tumor (Fig. 4e). The patient
was therefore diagnosed with non-malignant MCN-L and
an extensive left lobectomy and right hepaticojejunostomy
were performed.
Examination of the resected specimen confirmed that the
tumor originating from S4 of the liver had prolapsed into
the left hepatic duct and common bile duct (Fig. 5). Mi-
croscopic findings indicated that the cystic lesion was lined
with mucinous cuboidal epithelium, and OLS was observed
extensively in the cyst wall stroma (Fig. 6). The OLS was
positive for both progesterone and estrogen receptors.
MCN-L with low-grade dysplasia was diagnosed.
Discussion
The World Health Organization (WHO) classifies mucus-
producing bile duct tumors of the liver into intraductal
papillary neoplasm of the bile duct (IPNB) or MCN-L [1].
These concepts were established as counterparts to
intraductal papillary mucinous neoplasm (IPMN) of the
pancreas and mucinous cystic neoplasm of the pancreas
(MCN-P). IPNBs become papillary inside the bile duct and
secrete mucin in approximately one-third of all cases. They
show communication with the bile duct and do not exhibit
OLS. As in the case of IPMN of the pancreas, four phe-
notypes are known to exist––pancreatobiliary, intestinal,
oncocytic, and gastric. On the other hand, MCN-Ls are
cyst-forming epithelial tumors that are composed patho-
logically of mucus-producing cuboidal or columnar ep-
ithelium. They usually have no communication with the
bile duct and exhibit OLS.
MCN-Ls have been traditionally called biliary cystade-
nomas or biliary cystadenocarcinomas [2, 3]. The defini-
tions of these tumors have been controversial; however, in
recent years, OLS has been considered necessary for a
MCN-L diagnosis, and therefore the disease concept is now
being established. Thus, tumors that have been referred to
as biliary cystadenomas or biliary cystadenocarcinomas in
previous reports could be classified into tumors with and
without OLS. Most biliary cystic neoplasms that have been
Fig. 4 a Contrast abdominal CT revealed a cystic lesion with the
septal formation in the left hepatic lobe (S4) (arrow). b, c MRI
showed high signal intensities on T2-weighted images of the
components of the cyst (arrow). The septal formations were
connected to the left hepatic duct and common bile duct (arrow).
The spread of the tumor to the bile duct was suspected. d ERCP
revealed a filling defect in the upper bile duct (arrow). The lower tip
of the defect area was oval-shaped. Stenosis of the left hepatic duct
was also observed. e IDUS revealed the spread of the tumor to the
common bile duct, with the septal formations inside the tumor
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reported previously as biliary cystadenomas or cystadeno-
carcinomas without OLS are currently thought to be IPNBs
[2, 4–8]. Based on the 2010 WHO classifications, biliary
cystic neoplasm with OLS should be diagnosed as MCN-L.
Zen et al. [9] investigated 54 cases of MCN-L and re-
ported the following characteristics: MCN-Ls often oc-
curred in the left hepatic lobe (72 %), the mean age of
onset was 52.5 years, and they rarely developed in men
(over 90 % of the patients were women). In addition,
MCN-Ls are often large, with a mean size of 100 mm
(29–240 mm). There is little correlation with viral hepati-
tis, intrahepatic cholelithiasis, or liver cirrhosis, and
malignancy is uncommon, with 1 out of 54 cases exhibiting
micro-invasive carcinoma. Although rare, MCN-Ls have
the potential to be malignant. Even for asymptomatic cases,
surgery is generally preferable for MCN-L. MCN-Ps, the
same type of tumor but located in the pancreas, are known
to have relatively low malignant potential, but invasive
carcinomas have been reported to account for ap-
proximately 10 % of cases [10]. Zen et al. suggested that
both MCN-Ls and MCN-Ps exhibit low malignant poten-
tial; however, of the two, MCN-Ls exhibit lower malignant
potential [9].
Preoperative differentiation of benign and malignant
MCN-Ls is difficult. Previous reports of malignant MCN-
Ls indicate nodular components with contrast enhancement
effects within the cyst, ductal invasion, and metastasis to
other organs [2, 11]. In our cases, contrast CT showed no
nodules inside the cyst, no ductal invasion, and no metas-
tasis to other organs. There were no findings indicating
malignancy in the bile cytology. The above findings sug-
gested the presence of benign MCN-L preoperatively.
However, a definitive diagnosis can only be made based on
postoperative pathological findings.
Kubota et al. [12] investigated 119 cases of IPNB and 9
cases of MCN-L, all of which occurred in females, and
most MCN-L cases were asymptomatic in comparison with
the IPNB cases. They suggested that patients with IPNBs
may be more likely to develop symptoms such as cholan-
gitis and liver dysfunction due to communication with the
bile duct. However, the tumors of the 2 patients in the
present report had prolapsed into the bile duct and exhib-
ited expansive growth. Obstructive jaundice was therefore
observed.
We searched the literature for MCN-L cases in which
the tumor grew expansively in the bile duct over the past
10 years (from 2004 to 2014). In our literature search, we
used the keywords ‘‘biliary cystadenoma’’, ‘‘biliary cys-
tadenocarcinoma’’, and ‘‘mucinous cystic neoplasm of the
liver’’ to search PubMed and extracted cases with growth
in the bile duct. We only diagnosed cases with OLS as
MCN-Ls and excluded cases that did not exhibit OLS or
for which no mention of OLS was made. We also excluded
any cases that were complicated by IPNB.
As a result, 15 cases were extracted [13–27] and are
listed in Table 1. The mean age of these patients was
44.5 years (25-62 years), all of the patients were female,
and all showed the following symptoms: jaundice (9 pa-
tients), abdominal pain (9 patients), and liver dysfunction
(2 patients); some patients had multiple symptoms. Tumor
size was recorded in 11 of the 15 patients. The mean size
was 49.5 mm (18-79 mm); the primary tumor sites in-
cluded the left hepatic lobe (10 patients: 8 cases of S4, 1
case of S3, 1 case of unknown), the common bile duct (3
patients), and the left hepatic duct (2 patients). The tumor
Fig. 5 Examination of the resected specimen confirmed that the
tumor originated from S4 of the liver. It had prolapsed into the left
hepatic duct and common bile duct (arrow)
Fig. 6 Microscopic findings indicated that the cystic lesion was lined
with mucinous cuboidal epithelium, and OLS was observed exten-
sively in the cyst wall stroma. MCN-L with low-grade dysplasia was
diagnosed
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spread to both the left hepatic duct and the common bile
duct in 7 patients, only the common bile duct in 5 patients,
and only the left hepatic duct in 3 patients. ERCP images
were recorded for 7 patients. In all of the patients, the
images revealed the same characteristic oval-shaped filling
defects in the bile duct, as seen in the 2 patients in our
study. A hepatectomy and bile duct resection were per-
formed to completely remove the lesions. Pathological
examination indicated that none of tumors was malignant.
The MCN-Ls that spread to and grew in the bile duct
developed in patients who were younger than those de-
scribed in the report by Zen et al., and the tumors tended to
be smaller. This may have been because the spread of the
tumors to the bile duct is more likely to cause symptoms,
such as jaundice or cholangitis, leading to early detection.
The characteristic oval-shaped filling defects that are ob-
served with ERCP may be extremely useful in diagnosing
this tumor. The most common primary tumor site was S4 of
the liver. The primary tumor site was also S4 of the liver in
the 2 patients in our reports, suggesting that MCN-Ls that
develop from this site may be prone to prolapse into the
bile duct. This may be because the most common primary
site of MCN-L is S4 of the liver [2], but it is potentially an
interesting phenomenon. We hypothesize that because S4
of the liver is near the hepatic portal region and close to the
relatively thick central side of the bile duct, the tumors
originating from this site may be prone to prolapse into the
bile duct. MCN-Ls in the 15 cases that we reviewed were
all benign. Prolapse into the bile duct may be a finding
which suggests that the tumor is benign. However, as
malignant MCN-Ls are relatively uncommon, we have not
reviewed enough cases to date to make such conclusions.
In addition, we will discuss bile duct lesions of other liver
tumors and compare them with MCN-L. Bile duct invasion
of hepatocellular carcinomas (HCCs) is clinically rare, but
reports suggest that it has been observed in 5 % of HCCs in
autopsies [28]. Such cases exhibit irregular stenosis and
exclusion of the bile duct. There are three main categories of
cholangiocellular carcinoma (CCC): mass-forming (MF),
periductal infiltrative (IF), and intraductal growth (IG). Of
these, the IG type overlaps the IPNB concept proposed in
recent years, with irregular papillary tumors developing in
the bile duct. The frequency of the IG type is reported to be
4 % of CCC cases [29]. Papillary tumors are confirmed on
cholangiography and cholangioscopy. Growth of other tu-
mor-related lesions into the bile duct (focal nodular hyper-
plasia, hepatic adenoma, lymphoma, hepatoblastoma, and
mesenchymal tumor) is exceptionally rare.
The occurrence of MCN-Ls prolapsing into the bile duct
is unclear as it is an extremely rare tumor. Prolapse into the
bile duct has a strong impact, making it likely to be re-
ported. Examination of further cases is required. In MCN-
L, expansive growth is shown by prolapse into the bile duct
so that the smooth, round tumor occupies the lumen of the
bile duct. This development of the tumor, which is com-
pletely different from HCC invasion into the bile duct and
the IG type of CCC, can be said to be a characteristic
behavior of MCN-L.
MCN-L is basically considered to be a non-invasive,
benign tumor that does not grow invasively but grows
expansively. This tumor can prolapse into the bile duct and
then grow to fill the bile duct. ERCP can be used to confirm
the characteristic oval-shaped filling defect in the bile duct.
Even if the entire oval shape is not revealed, as in case 2,
careful attention should be paid to the fact that the margins
of the filling defect are oval. In addition, cholangioscopy,
IDUS, and EUS are useful for differentiating these tumors
from stones.
We described 2 MCN-L cases that exhibited extremely
interesting spread patterns. Prolapse into the bile duct and
expansive growth may be a characteristic behavior of
MCN-L. Additional data from more cases needs to be col-
lected for further elucidation of MCN-L’s pathophysiology.
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